These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6486264)

  • 21. The dex/CRH test--is it better than the DST?
    Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The overnight dexamethasone suppression test: clinical and theoretical review.
    Gwirtsman H; Gerner RH; Sternbach H
    J Clin Psychiatry; 1982 Aug; 43(8):321-7. PubMed ID: 7047505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dexamethasone suppression in the depressed patient. Reflections apropos of an experience].
    Jonas C; Etienne T; Valat C
    Encephale; 1983; 9(2):111-22. PubMed ID: 6641613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The noncompliance factor in the dexamethasone suppression test.
    Remillard AJ; O'Reilly R; Gorecki DK; Blackshaw SL; Quinn D; Keegan DL
    Biol Psychiatry; 1993 May; 33(10):755-6. PubMed ID: 8353173
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of the dexamethasone test in the differential diagnosis of depressive states].
    Nuller IuL; Ostroumova MN; Gordon OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of biologic markers in a general hospital affective disorders program.
    Lieber AL; Newbury N
    J Clin Psychiatry; 1985 Jun; 46(6):217-21. PubMed ID: 3922959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiety/depression: current management and future directions. Biologic markers and treatment response.
    Carroll BJ
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):30-40. PubMed ID: 6348035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients.
    Meltzer HY; Fang VS; Tricou BJ; Robertson A; Piyaka SK
    Am J Psychiatry; 1982 Jun; 139(6):763-8. PubMed ID: 7081489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial dexamethasone suppression tests in psychiatric illness: Part III. The influence of intervening variables.
    Baumgartner A; Haack D; Vecsei P
    Psychiatry Res; 1986 May; 18(1):45-64. PubMed ID: 3737787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression and dexamethasone suppression testing in children and adolescents.
    Emslie GJ; Weinberg WA; Rush AJ; Weissenburger J; Parkin-Feigenbaum L
    J Child Neurol; 1987 Jan; 2(1):31-7. PubMed ID: 3624827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.
    Greden JF; Gardner R; King D; Grunhaus L; Carroll BJ; Kronfol Z
    Arch Gen Psychiatry; 1983 May; 40(5):493-500. PubMed ID: 6340634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dexamethasone suppression test in acute mania.
    Godwin CD
    J Affect Disord; 1984 Dec; 7(3-4):281-6. PubMed ID: 6241210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of plasma cortisol and corticosterone in the dexamethasone suppression test for melancholia.
    Wilens TE; Ritchie JC; Carroll BJ
    Psychoneuroendocrinology; 1984; 9(1):45-55. PubMed ID: 6739664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial dexamethasone suppression test in psychiatric inpatients.
    Hwu HG; Lin HN
    Biol Psychiatry; 1990 Mar; 27(6):609-16. PubMed ID: 2322620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DST abnormality as a predictor of course in major depression.
    Coryell W
    J Affect Disord; 1990 Jul; 19(3):163-9. PubMed ID: 2145336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone suppression test: a review of contemporary confusion.
    Carroll BJ
    J Clin Psychiatry; 1985 Feb; 46(2 Pt 2):13-24. PubMed ID: 3881417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone suppression test as an aid for selection of specific antidepressant drugs in patients with endogenous depression.
    Rihmer Z; Arató M; György S; Révai K; Demeter E
    Pharmacopsychiatry; 1985 Sep; 18(5):306-8. PubMed ID: 4048265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dexamethasone suppression test in mixed bipolar disorder.
    Evans DL; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):615-7. PubMed ID: 6846594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Re-analysis of the diagnostic significance of the dexamethasone suppression test in depression].
    Shen QJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):279-83. PubMed ID: 3833512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.